![An update on polymyalgia rheumatica - Lundberg - 2022 - Journal of Internal Medicine - Wiley Online Library An update on polymyalgia rheumatica - Lundberg - 2022 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/588ba535-f09f-43be-9efa-1df3a73498db/joim13525-fig-0002-m.jpg)
An update on polymyalgia rheumatica - Lundberg - 2022 - Journal of Internal Medicine - Wiley Online Library
![Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient. - Abstract - Europe PMC Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5644293/bin/IJMR-145-593-g001.jpg)
Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient. - Abstract - Europe PMC
![What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica? | Annals of the Rheumatic Diseases What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica? | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/8/e133/F1.large.jpg)
What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica? | Annals of the Rheumatic Diseases
![Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study | RMD Open Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study | RMD Open](https://rmdopen.bmj.com/content/rmdopen/3/1/e000426/F1.large.jpg)
Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study | RMD Open
![PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial | Trials | Full Text PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-022-06263-3/MediaObjects/13063_2022_6263_Fig1_HTML.png)